CGM and glucose test for cystic fibrosis related diabetes
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study tests if a continuous glucose monitor (CGM) along with a standard glucose drink test can better detect diabetes in people with cystic fibrosis. It is for adults who do not yet have diabetes and are generally healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older) with cystic fibrosis
- You are seen at Froedtert Multidisciplinary CF Clinic
- You had a glucose tolerance test in 2024 showing normal or impaired glucose tolerance (not diabetes)
- You are in your usual good health (no current infections or hospital stays)
- You are not currently taking diabetes medications or diagnosed with cystic fibrosis related diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the body handles sugar in people with cystic fibrosis related diabetes. Researchers want to learn more about glucose metabolism to improve care for people with CFRD.
This study uses continuous glucose monitoring (a sensor that checks blood sugar trends) to understand how sugar handling changes over time in people with cystic fibrosis. It may help doctors spot early “pre-diabetes” or abnormal sugar patterns sooner.
This trial studies whether a low glycemic load (a specific way of choosing carbohydrates) improves blood sugar control and body composition in adults with cystic fibrosis–related diabetes. It may help reduce blood sugar problems and support healthier weight and body measurements.
This study checks if a continuous glucose monitor (a small device that tracks blood sugar levels throughout the day) works well for children with cystic fibrosis who have early blood sugar problems. It could help doctors better manage these issues before they become diabetes.
This study will look at how well Dexcom continuous glucose monitors (CGMs) work in real life. It helps people with diabetes track their blood sugar levels and may lead to better control of their condition.
This study tests a continuous glucose monitor (a small sensor that tracks your blood sugar) for 20 days. It's for people with prediabetes to see how their blood sugar changes throughout the day and potentially help manage their condition.
Hear when a new Cystic Fibrosis-related Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.